Molbio Diagnostics Plans IPO After Truenat Platform Success

Molbio Diagnostics, which makes a special test machine called Truenat, is getting ready to sell shares to the public (IPO).

Truenat helps diagnose diseases where lab facilities aren't easily available and has been patented in many countries.

The company's testing platform provides quick results, especially for diseases like TB and COVID.

Molbio earned an award for its digital transformation.

The company's revenue and profits have increased significantly.

Molbio will use the money from the IPO to improve its research, build better facilities and expand production.

The Truenat platform plays a vital role in controlling the spread of Tuberculosis in India.